• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养干预靶向非酒精性脂肪性肝病肠道菌群的研究进展

Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date.

机构信息

Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, 61-701 Poznań, Poland.

Department of Internal Medicine, Metabolic Disorders, and Hypertension, Poznań University of Medical Sciences, 61-701 Poznań, Poland.

出版信息

Int J Environ Res Public Health. 2021 Feb 8;18(4):1616. doi: 10.3390/ijerph18041616.

DOI:10.3390/ijerph18041616
PMID:33567710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7916007/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a significant clinical and epidemiological problem that affects around 25% of the adult global population. A large body of clinical evidence highlights that NAFLD is associated with increased liver-related morbidity and mortality and an increased risk of cardiovascular disease, extrahepatic cancers, type 2 diabetes, and chronic kidney disease. Recently, a series of studies revealed the pivotal role of gut microbiota (GM) dysbiosis in NAFLD's pathogenesis. The GM plays an essential role in different metabolic pathways, including the fermentation of diet polysaccharides, energy harvest, choline regulation, and bile acid metabolism. One of the most critical factors in GM stabilization is the diet; therefore, nutritional therapyappearsto be a promising tool in NAFLD therapy. This paper aims to review the current knowledge regardingthe nutritional approach and its implications with GM and NAFLD treatment. We discuss the positive impact of probiotics, prebiotics, and symbiotics in a reverse dysbiosis state in NAFLD and show the potential beneficial effects of bioactive substances from the diet. The full description of the mechanism of action and comprehensive examination of the impact of nutritional interventions on GM modulation may, in the future, be a simple but essential tool supporting NAFLD therapy.

摘要

非酒精性脂肪性肝病(NAFLD)是一个重大的临床和流行病学问题,影响着全球约 25%的成年人。大量临床证据表明,NAFLD 与肝脏相关发病率和死亡率的增加以及心血管疾病、肝外癌症、2 型糖尿病和慢性肾脏病的风险增加有关。最近,一系列研究揭示了肠道微生物群(GM)失调在 NAFLD 发病机制中的关键作用。GM 在不同的代谢途径中发挥着重要作用,包括饮食多糖的发酵、能量收获、胆碱调节和胆汁酸代谢。GM 稳定的最重要因素之一是饮食;因此,营养疗法似乎是 NAFLD 治疗的一种有前途的工具。本文旨在综述目前关于营养方法及其与 GM 和 NAFLD 治疗关系的知识。我们讨论了益生菌、益生元和共生体在 NAFLD 中逆向失调状态下的积极影响,并展示了饮食中的生物活性物质的潜在有益作用。全面描述作用机制并综合检查营养干预对 GM 调节的影响,将来可能成为支持 NAFLD 治疗的一种简单但基本的工具。

相似文献

1
Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date.营养干预靶向非酒精性脂肪性肝病肠道菌群的研究进展
Int J Environ Res Public Health. 2021 Feb 8;18(4):1616. doi: 10.3390/ijerph18041616.
2
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?益生菌在非酒精性脂肪性肝病中的作用:肠道微生物组是否重要?
Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837.
3
Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.综述文章:细菌可以成为药物吗?益生菌和益生元作为非酒精性脂肪性肝病治疗手段的潜力。
Aliment Pharmacol Ther. 2019 Sep;50(6):628-639. doi: 10.1111/apt.15416. Epub 2019 Aug 2.
4
Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.非酒精性脂肪性肝病:从肠道微生物群作用到基于微生物的治疗方法。
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):613-627. doi: 10.1007/s10096-019-03746-1. Epub 2019 Dec 11.
5
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.了解肠道微生物组和微生物代谢物在非酒精性脂肪性肝病中的作用:当前的证据和观点。
Biomolecules. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056.
6
Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.调控非酒精性脂肪性肝病的肠道微生物组:益生菌、益生元、合生元和抗生素。
J Microbiol. 2018 Dec;56(12):855-867. doi: 10.1007/s12275-018-8346-2. Epub 2018 Oct 25.
7
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).肠道微生物组与非酒精性脂肪性肝病(NAFLD)之间的联系。
Cell Mol Life Sci. 2019 Apr;76(8):1541-1558. doi: 10.1007/s00018-019-03011-w. Epub 2019 Jan 25.
8
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.肠-肝轴、肠道微生物群及其在肝脏疾病治疗中的调控:文献综述。
Int J Mol Sci. 2019 Jan 17;20(2):395. doi: 10.3390/ijms20020395.
9
The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease.肠道微生物组改变在非酒精性脂肪性肝病发病机制中的作用。
Curr Opin Infect Dis. 2021 Oct 1;34(5):477-482. doi: 10.1097/QCO.0000000000000759.
10
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates.了解肠道微生物失调对非酒精性脂肪性肝病的影响及益生菌的可能作用:最新进展。
Int J Biol Sci. 2021 Feb 8;17(3):818-833. doi: 10.7150/ijbs.56214. eCollection 2021.

引用本文的文献

1
The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017-2020.肠道微生物群饮食指数与非酒精性脂肪性肝病和肝纤维化之间的关联:来自2017 - 2020年美国国家健康与营养检查调查(NHANES)的证据
BMC Gastroenterol. 2025 Mar 12;25(1):163. doi: 10.1186/s12876-025-03756-8.
2
The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies.肠道菌群在代谢功能障碍相关脂肪性肝病中的作用及治疗策略
Front Med (Lausanne). 2025 Jan 7;11:1490929. doi: 10.3389/fmed.2024.1490929. eCollection 2024.
3
Mutual Interactions of Silymarin and Colon Microbiota in Healthy Young and Healthy Elder Subjects.水飞蓟素与健康青年和健康老年受试者肠道微生物群的相互作用。
Mol Nutr Food Res. 2024 Nov;68(22):e2400500. doi: 10.1002/mnfr.202400500. Epub 2024 Oct 30.
4
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease.益生元和益生菌:非酒精性脂肪性肝病的治疗工具。
Int J Mol Sci. 2023 Oct 5;24(19):14918. doi: 10.3390/ijms241914918.
5
Alanyl-Glutamine Dipeptide Attenuates Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice by Improving Gut Microbiota Dysbiosis.丙氨酰-谷氨酰胺二肽通过改善肠道微生物失调减轻高脂饮食诱导的小鼠非酒精性脂肪肝疾病。
Nutrients. 2023 Sep 14;15(18):3988. doi: 10.3390/nu15183988.
6
Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver Disease.多组学营养方法靶向代谢相关脂肪性肝病。
Genes (Basel). 2022 Nov 17;13(11):2142. doi: 10.3390/genes13112142.
7
Effects of Non-Polar Dietary and Endogenous Lipids on Gut Microbiota Alterations: The Role of Lipidomics.非极性膳食和内源性脂质对肠道微生物组变化的影响:脂质组学的作用。
Int J Mol Sci. 2022 Apr 7;23(8):4070. doi: 10.3390/ijms23084070.

本文引用的文献

1
The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial.凝结芽孢杆菌补充剂对非酒精性脂肪性肝病患者的影响:一项随机、安慰剂对照的临床试验。
Clin Nutr ESPEN. 2020 Oct;39:53-60. doi: 10.1016/j.clnesp.2020.06.020. Epub 2020 Jul 24.
2
Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis.白藜芦醇补充剂对非酒精性脂肪性肝病患者的影响:一项荟萃分析。
Nutrients. 2020 Aug 13;12(8):2435. doi: 10.3390/nu12082435.
3
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.系统评价与荟萃分析:维生素 E 补充剂对非酒精性脂肪性肝病成年患者的影响。
J Gastroenterol Hepatol. 2021 Feb;36(2):311-319. doi: 10.1111/jgh.15221. Epub 2020 Sep 10.
4
The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet.代谢性内毒素血症的发展取决于甜味剂的类型和饮食中饱和脂肪的存在。
Gut Microbes. 2020 Nov 9;12(1):1801301. doi: 10.1080/19490976.2020.1801301.
5
Protective effect of probiotics in patients with non-alcoholic fatty liver disease.益生菌对非酒精性脂肪性肝病患者的保护作用。
Medicine (Baltimore). 2020 Aug 7;99(32):e21464. doi: 10.1097/MD.0000000000021464.
6
Scientific evidence underlying contraindications to the ketogenic diet: An update. ketogenic 饮食禁忌的科学依据:更新。
Obes Rev. 2020 Oct;21(10):e13053. doi: 10.1111/obr.13053. Epub 2020 Jul 10.
7
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD.高蛋白摄入与非酒精性脂肪性肝病患者的组织学疾病活动相关。
Hepatol Commun. 2020 Mar 26;4(5):681-695. doi: 10.1002/hep4.1509. eCollection 2020 May.
8
You Are What You Eat-The Relationship between Diet, Microbiota, and Metabolic Disorders-A Review.你吃什么就是什么——饮食、微生物组和代谢紊乱之间的关系——综述。
Nutrients. 2020 Apr 15;12(4):1096. doi: 10.3390/nu12041096.
9
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎:综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
10
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.生酮饮食对非酒精性脂肪性肝病的有益作用:文献综述。
Obes Rev. 2020 Aug;21(8):e13024. doi: 10.1111/obr.13024. Epub 2020 Mar 24.